Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF)2- and TRAF5-mediated NF-κB activation

We investigated the intracellular signaling of OX40, a member of the tumor necrosis factor receptor family. Activation of NF-kappa B in OX40-transfected HSB-2 cells was detected by electrophoretic mobility shift assay within 30 min after the binding of the Ligand gp34. In vitro binding experiments showed that tumor necrosis factor receptor-associated factor (TRAF) 1, TRAF2, TRAF3, and TRAF5 but not TRAF4 associated with glutathione S-transferase-OX40 fusion protein, The cotransfection experiments using human embryo kidney cell derived HEK 293T cells showed that TRAF2, TRAF3, and TRAF5 associated with OX40 in vivo. Studies with OX40 deletion mutants demonstrated that the cytoplasmic portion consisting of amino acid sequence 256-263 (GGSFRTPI) was required for the association with TRAFs and NF-kappa activation. The introduction of the dominant negative mutants of TR4F2 and TRAF5 into HSB-2-OX40 cells suppressed NF-kappa B activation in a dose-dependent manner. In addition, the introduction of TRAF3 together with the dominant negative mutants of TRAF2 or TRAF5 further reduced NF-kappa B activation. These results indicate that the NF-kappa B activation resulting from OX40 stimulation is mediated by both TRAF2 and TRAF5, and is likely to be negatively modulated by TRAF3.